 The high frequency of off-target activity in CRISPR-Cas9 is a major concern for therapeutic and clinical applications, but strategies to minimize off-target cleavage can improve specificity and enable faithful interpretation of genome editing data, facilitating basic and clinical application of this technology. This article was authored by Xiao Huizhong, Louis Y.T., Xiao Geng Wang, and others.